Trials / Completed
CompletedNCT03778242
Tranexamic Acid in Pregnant Women Undergoing Cesarean Section.
The Adjunctive Role of Temporary Uterine Packing Combined With Topical Tranexamic Acid for Reducing Blood Loss During Hemorrhagic Cesarean Delivery: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Aswan University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Purpose to evaluate the effects of topical tranexamic acid (TA) on reducing post-partum hemorrhage in pregnant women with hemorrhagic cesarean section
Detailed description
Uterine atony is the major cause of postpartum hemorrhage (PPH), accounting for up to 80% of PPH cases. PPH is the leading cause of maternal morbidity and mortality worldwide, resulting in up to 28% of maternal deaths. Therefore, inducing a rapid and effective uterine contraction following delivery is an important issue. The aim of the study is to To explore the efficacy and safety of temporary uterine packing combined with topical tranexamic acid (TA) as an adjunct for reducing blood loss during a hemorrhagic cesarean delivery (CD), compared with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Topical tranexamic acid | temporary uterine packing with gauze of the dimensions soaked with 2 gm tranexamic diluted in 60ml saline acid |
| DRUG | normal saline | 2 placebo ampoules to TA in 100 ml saline by slow infusion |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2022-03-30
- Completion
- 2022-07-01
- First posted
- 2018-12-19
- Last updated
- 2023-04-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03778242. Inclusion in this directory is not an endorsement.